美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Impact Biomedical, Inc.

0.4026

-0.0344-7.87%

盤後：0.4000-0.0026-0.65%19:58 EDT

成交量：43.83萬

成交額：18.07萬

市值：486.56萬

市盈率：-0.18

高：0.4317

開：0.4107

低：0.3953

收：0.4370

資料載入中...

總覽公司新聞公告

Form 4 | Impact Biomedical董事Chan Heng Fai Ambrose減持351,555股

老虎公告助手

Form 4 | Impact Biomedical董事 Chan Heng Fai Ambrose 於2025年4月2日出售了885,276股

老虎公告助手

Matinas Biopharma Holdings, Inc.盤中異動下午盤股價大跌5.45%

Essa Pharma Inc.盤中異動急速下跌5.06%

Xencor, Inc.盤中異動股價大跌5.04%

Nrx Pharmaceuticals, Inc.盤中異動快速下挫5.88%報1.76美元

Okyo Pharma Ltd Com Npv (Post Rev Split)盤中異動股價大跌6.96%報1.14美元

Argenx Se盤中異動快速跳水5.05%報560.26美元

Molecular Partners Ag盤中異動大幅拉昇6.18%報3.95美元

Immunocore Hldgs Plc盤中異動股價大跌5.13%

Verrica製藥盤中異動股價大漲5.79%

Immuron Limited盤中異動臨近午盤股價大跌5.00%

Moolec Science Sa股價飆升14.44% 市值漲384.08萬美元

Genenta Science Spa盤中異動臨近午盤快速下挫6.63%

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股價重挫16.11% 市值跌12.55萬美元

Glycomimetics, Inc.盤中異動早盤急速拉昇5.35%報0.195美元

Jaguar Health, Inc.盤中異動股價大跌5.71%報4.29美元

Forte Biosciences, Inc.盤中異動急速下挫5.02%報6.25美元

Igc Pharma, Inc.盤中異動早盤急速跳水5.23%報0.265美元

Tnf Pharmaceuticals, Inc.盤中異動跌3.41% 換手率達43.78%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IBO/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBO\",,,,,undefined,":{"symbol":"IBO","market":"US","secType":"STK","nameCN":"Impact Biomedical, Inc.","latestPrice":0.4026,"timestamp":1744920000000,"preClose":0.437,"halted":0,"volume":438334,"hourTrading":{"tag":"盘后","latestPrice":0.4,"preClose":0.4026,"latestTime":"19:58 EDT","volume":67864,"amount":28211.9398,"timestamp":1744934308146},"delay":0,"floatShares":10459196,"shares":12085412,"eps":-2.299999,"marketStatus":"休市中","change":-0.0344,"latestTime":"04-17 16:00:00 EDT","open":0.4107,"high":0.4317,"low":0.3953,"amount":180733.88364668,"amplitude":0.083295,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.299999,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1721361600000,"exchange":"AMEX","adjPreClose":0.437,"preHourTrading":{"tag":"盘前","latestPrice":0.4268,"preClose":0.437,"latestTime":"09:23 EDT","volume":7439,"amount":3225.7557164,"timestamp":1744896222062},"postHourTrading":{"tag":"盘后","latestPrice":0.4,"preClose":0.4026,"latestTime":"19:58 EDT","volume":67864,"amount":28211.9398,"timestamp":1744934308146},"volumeRatio":0.3388491710504796,"impliedVol":0.2693,"impliedVolPercentile":0.992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBO\",,,,,undefined,":{"symbol":"IBO","floatShares":10459196,"roa":"-6.54%","roe":"-139.55%","lyrEps":-2.296891,"volumeRatio":0.3388491710504796,"shares":12085412,"dividePrice":0,"high":0.4317,"amplitude":0.083295,"preClose":0.437,"low":0.3953,"week52Low":0.37,"pbRate":"1.16","week52High":6.17,"institutionHeld":0,"latestPrice":0.4026,"eps":-2.299999,"divideRate":0,"volume":438334,"delay":0,"ttmEps":-2.299999,"open":0.4107,"prevYearClose":1.45,"prevWeekClose":0.4951,"prevMonthClose":0.87,"prevQuarterClose":0.87,"fiveDayClose":0.51,"twentyDayClose":2.08,"sixtyDayClose":1.56},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBO\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1105714760","title":"Form 4 | Impact Biomedical董事Chan Heng Fai Ambrose減持351,555股","url":"https://stock-news.laohu8.com/highlight/detail?id=1105714760","media":"老虎公告助手","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105714760?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 05:20","pubTimestamp":1744060822,"startTime":"0","endTime":"0","summary":"Impact Biomedical Inc.（股票代码：IBO）董事Chan Heng Fai Ambrose于2025年4月3日减持了351,555股普通股票，平均售价为0.495美元此次减持表明了公司最高管理层对于当前股价的不看好，此次减持可能对投资者构成利空信号，建议投资者密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Form 4 | Impact Biomedical董事Chan Heng Fai Ambrose减持351,555股","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBO"],"gpt_icon":0},{"id":"1106226463","title":"Form 4 | Impact Biomedical董事 Chan Heng Fai Ambrose 於2025年4月2日出售了885,276股","url":"https://stock-news.laohu8.com/highlight/detail?id=1106226463","media":"老虎公告助手","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106226463?lang=zh_tw&edition=fundamental","pubTime":"2025-04-05 05:20","pubTimestamp":1743801612,"startTime":"0","endTime":"0","summary":"Impact Biomedical Inc.的董事兼10%股东Chan Heng Fai Ambrose在2025年4月2日至4月4日期间通过其控制的公司Alset International Ltd和Alset Inc密集出售普通股，总计885,276股。此类密集的减持行为可能反映了公司股票被高估的观点，投资者应密切关注该消息对股票价格的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Form 4 | Impact Biomedical董事 Chan Heng Fai Ambrose 于2025年4月2日出售了885,276股","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBO"],"gpt_icon":0},{"id":"2525359587","title":"Matinas Biopharma Holdings, Inc.盤中異動 下午盤股價大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525359587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525359587?lang=zh_tw&edition=fundamental","pubTime":"2025-04-05 01:24","pubTimestamp":1743787444,"startTime":"0","endTime":"0","summary":"北京时间2025年04月05日01时24分，Matinas Biopharma Holdings, Inc.股票出现异动，股价快速跳水5.45%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体跌幅为3.05%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Impact Biomedical, Inc.、Aldeyra Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Impact Biomedical, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为2270.30%、813.22%、353.75%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Impact Biomedical, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 ，振幅分别为455.04%、77.80%、66.67%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，专注于识别和开发新型医药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405012404a44e0a77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405012404a44e0a77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MTNB","BK4139","IBO"],"gpt_icon":0},{"id":"2525733985","title":"Essa Pharma Inc.盤中異動 急速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525733985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525733985?lang=zh_tw&edition=fundamental","pubTime":"2025-04-05 00:49","pubTimestamp":1743785382,"startTime":"0","endTime":"0","summary":"北京时间2025年04月05日00时49分，Essa Pharma Inc.股票出现异动，股价急速跳水5.06%。截至发稿，该股报1.50美元/股，成交量16.2477万股，换手率0.37%，振幅5.06%。Essa Pharma Inc.股票所在的生物技术行业中，整体跌幅为2.86%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Impact Biomedical, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Biodexa Pharmaceuticals Plc、Impact Biomedical, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为2253.75%、792.45%、347.44%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Impact Biomedical, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 ，振幅分别为455.04%、77.80%、66.67%。Essa Pharma Inc.公司简介：ESSA Pharma Inc是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405004942a44e03fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405004942a44e03fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EPIX","BK4139","IBO","BK4007"],"gpt_icon":0},{"id":"2525778738","title":"Xencor, Inc.盤中異動 股價大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525778738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525778738?lang=zh_tw&edition=fundamental","pubTime":"2025-04-05 00:48","pubTimestamp":1743785290,"startTime":"0","endTime":"0","summary":"北京时间2025年04月05日00时48分，Xencor, Inc.股票出现异动，股价快速跳水5.04%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为2.79%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405004810a44e03a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405004810a44e03a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4007","IBO","BK4139"],"gpt_icon":0},{"id":"2525268738","title":"Nrx Pharmaceuticals, Inc.盤中異動 快速下挫5.88%報1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525268738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525268738?lang=zh_tw&edition=fundamental","pubTime":"2025-04-05 00:33","pubTimestamp":1743784418,"startTime":"0","endTime":"0","summary":"北京时间2025年04月05日00时33分，Nrx Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.88%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.73%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。消息层面，截至00时33分，《NRX Pharmaceuticals获BTIG首次覆盖，给予买入评级, 目标价18.00美元。》资讯为影响Nrx Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405003338972e9204&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405003338972e9204&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBO","BK4007","NRXP"],"gpt_icon":0},{"id":"2525738292","title":"Okyo Pharma Ltd Com Npv (Post Rev Split)盤中異動 股價大跌6.96%報1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525738292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525738292?lang=zh_tw&edition=fundamental","pubTime":"2025-04-05 00:27","pubTimestamp":1743784058,"startTime":"0","endTime":"0","summary":"北京时间2025年04月05日00时27分，Okyo Pharma Ltd Com Npv 股票出现异动，股价急速下跌6.96%。Okyo Pharma Ltd Com Npv 股票所在的生物技术行业中，整体跌幅为2.58%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Impact Biomedical, Inc.、Aldeyra Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Impact Biomedical, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为2243.35%、771.56%、343.31%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Impact Biomedical, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 ，振幅分别为455.04%、68.25%、66.67%。Okyo Pharma Ltd Com Npv 公司简介：OKYO Pharma Ltd 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040500273894cc1f06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040500273894cc1f06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OKYO","BK4139","IBO","BK4007"],"gpt_icon":0},{"id":"2525474780","title":"Argenx Se盤中異動 快速跳水5.05%報560.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525474780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525474780?lang=zh_tw&edition=fundamental","pubTime":"2025-04-05 00:21","pubTimestamp":1743783682,"startTime":"0","endTime":"0","summary":"北京时间2025年04月05日00时21分，Argenx Se股票出现波动，股价急速下跌5.05%。截至发稿，该股报560.26美元/股，成交量22.7522万股，换手率0.37%，振幅3.66%。Argenx Se股票所在的生物技术行业中，整体跌幅为2.57%。Argenx Se公司简介：Argenx是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405002122aa2c5c48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405002122aa2c5c48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBO","BK4007","BK4139","LU0320765992.SGD","BK4505","BK4585","LU0109394709.USD","BK4588","LU0889565916.HKD","ARGX"],"gpt_icon":0},{"id":"2525050780","title":"Molecular Partners Ag盤中異動 大幅拉昇6.18%報3.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525050780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525050780?lang=zh_tw&edition=fundamental","pubTime":"2025-04-05 00:19","pubTimestamp":1743783590,"startTime":"0","endTime":"0","summary":"北京时间2025年04月05日00时19分，Molecular Partners Ag股票出现波动，股价大幅上涨6.18%。截至发稿，该股报3.95美元/股，成交量379股，换手率0.00%，振幅0.00%。Molecular Partners Ag股票所在的生物技术行业中，整体跌幅为2.68%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040500195094cc1e24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040500195094cc1e24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MOLN","IBO","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2525356047","title":"Immunocore Hldgs Plc盤中異動 股價大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525356047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525356047?lang=zh_tw&edition=fundamental","pubTime":"2025-04-05 00:17","pubTimestamp":1743783460,"startTime":"0","endTime":"0","summary":"北京时间2025年04月05日00时17分，Immunocore Hldgs Plc股票出现波动，股价急速下跌5.13%。截至发稿，该股报27.55美元/股，成交量10.3857万股，换手率0.21%，振幅3.29%。Immunocore Hldgs Plc股票所在的生物技术行业中，整体跌幅为2.46%。Immunocore Hldgs Plc公司简介：Immunocore Holdings PLC是一家商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040500174094cc1de7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040500174094cc1de7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","IMCR","IBO","BK4007","BK4139"],"gpt_icon":0},{"id":"2525978081","title":"Verrica製藥盤中異動 股價大漲5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525978081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525978081?lang=zh_tw&edition=fundamental","pubTime":"2025-04-05 00:08","pubTimestamp":1743782912,"startTime":"0","endTime":"0","summary":"北京时间2025年04月05日00时08分，Verrica制药股票出现波动，股价快速拉升5.79%。截至发稿，该股报0.444美元/股，成交量12.6553万股，换手率0.14%，振幅8.64%。Verrica制药股票所在的生物技术行业中，整体跌幅为2.05%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405000832972e8f09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405000832972e8f09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007","IBO"],"gpt_icon":0},{"id":"2525978779","title":"Immuron Limited盤中異動 臨近午盤股價大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525978779","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525978779?lang=zh_tw&edition=fundamental","pubTime":"2025-04-04 23:50","pubTimestamp":1743781850,"startTime":"0","endTime":"0","summary":"北京时间2025年04月04日23时50分，Immuron Limited股票出现波动，股价快速跳水5.00%。截至发稿，该股报1.71美元/股，成交量579股，换手率0.01%，振幅2.50%。Immuron Limited股票所在的生物技术行业中，整体跌幅为1.98%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404235050972e8d00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404235050972e8d00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139","BK4007","IBO"],"gpt_icon":0},{"id":"2525870027","title":"Moolec Science Sa股價飆升14.44% 市值漲384.08萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525870027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525870027?lang=zh_tw&edition=fundamental","pubTime":"2025-04-04 23:37","pubTimestamp":1743781021,"startTime":"0","endTime":"0","summary":"北京时间2025年04月04日23时37分，Moolec Science Sa股票出现波动，股价大幅上涨14.44%。Moolec Science Sa股票所在的生物技术行业中，整体跌幅为2.03%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Impact Biomedical, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Impact Biomedical, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为2201.94%、743.47%、338.09%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Impact Biomedical, Inc.、Virpax Pharmaceuticals Inc，振幅分别为455.04%、68.25%、60.00%。Moolec Science Sa公司简介：Moolec Science SA 是一家以科学为基础的成分公司，专注于通过分子农业在植物中生产真正的动物蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404233702a6afc8e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404233702a6afc8e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MLEC","BK4212","IBO"],"gpt_icon":0},{"id":"2524782914","title":"Genenta Science Spa盤中異動 臨近午盤快速下挫6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524782914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524782914?lang=zh_tw&edition=fundamental","pubTime":"2025-04-04 23:33","pubTimestamp":1743780826,"startTime":"0","endTime":"0","summary":"北京时间2025年04月04日23时33分，Genenta Science Spa股票出现异动，股价大幅跳水6.63%。截至发稿，该股报3.62美元/股，成交量693股，换手率0.00%，振幅2.58%。Genenta Science Spa股票所在的生物技术行业中，整体跌幅为1.97%。Genenta Science Spa公司简介：Genenta Science SPA 是一家临床阶段生物技术公司，致力于开发用于治疗实体瘤和癌症的造血干细胞基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404233346972e8ace&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404233346972e8ace&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GNTA","BK4139","IBO"],"gpt_icon":0},{"id":"2525673885","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股價重挫16.11% 市值跌12.55萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525673885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525673885?lang=zh_tw&edition=fundamental","pubTime":"2025-04-04 23:27","pubTimestamp":1743780421,"startTime":"0","endTime":"0","summary":"北京时间2025年04月04日23时27分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现波动，股价快速跳水16.11%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体跌幅为1.56%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404232701a44df051&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404232701a44df051&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBO","BK4007","SABSW"],"gpt_icon":0},{"id":"2524784689","title":"Glycomimetics, Inc.盤中異動 早盤急速拉昇5.35%報0.195美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524784689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524784689?lang=zh_tw&edition=fundamental","pubTime":"2025-04-04 23:11","pubTimestamp":1743779498,"startTime":"0","endTime":"0","summary":"北京时间2025年04月04日23时11分，Glycomimetics, Inc.股票出现异动，股价快速上涨5.35%。截至发稿，该股报0.195美元/股，成交量12.031万股，换手率0.19%，振幅6.10%。Glycomimetics, Inc.股票所在的生物技术行业中，整体跌幅为1.41%。Glycomimetics, Inc.公司简介：GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404231138a6afc3d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404231138a6afc3d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","IBO","GLYC"],"gpt_icon":0},{"id":"2525717787","title":"Jaguar Health, Inc.盤中異動 股價大跌5.71%報4.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525717787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525717787?lang=zh_tw&edition=fundamental","pubTime":"2025-04-04 23:11","pubTimestamp":1743779485,"startTime":"0","endTime":"0","summary":"北京时间2025年04月04日23时11分，Jaguar Health, Inc.股票出现异动，股价大幅下挫5.71%。截至发稿，该股报4.29美元/股，成交量1.3663万股，换手率2.08%，振幅6.15%。Jaguar Health, Inc.股票所在的生物技术行业中，整体跌幅为1.41%。Jaguar Health, Inc.公司简介：Jaguar Health Inc 是一家商业阶段的制药公司，专注于为患有胃肠道疾病的人和动物开发新型、植物性、非阿片类药物且可持续衍生的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404231126a6afc3cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404231126a6afc3cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBO","BK4007","JAGX"],"gpt_icon":0},{"id":"2524784550","title":"Forte Biosciences, Inc.盤中異動 急速下挫5.02%報6.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524784550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524784550?lang=zh_tw&edition=fundamental","pubTime":"2025-04-04 23:10","pubTimestamp":1743779402,"startTime":"0","endTime":"0","summary":"北京时间2025年04月04日23时10分，Forte Biosciences, Inc.股票出现异动，股价急速下挫5.02%。Forte Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.48%。Forte Biosciences, Inc.公司简介：Forte Biosciences Inc 是一家生物制药公司，正在通过临床前试验推进其候选产品 FB-102 的研发，这是一种专有的治疗分子，在移植物抗宿主病，白癜风和斑秃等适应症方面具有广泛的自身免疫应用潜力。该信息摘要如下：Chardan Capital：维持Forte Biosciences评级，由买入调整至买入评级, 目标价由64.00美元调整至61.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404231002a44ded16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404231002a44ded16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","IBO","BK4588","BK4153","AA","BK4007","BK4139","FBRX"],"gpt_icon":0},{"id":"2524356781","title":"Igc Pharma, Inc.盤中異動 早盤急速跳水5.23%報0.265美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524356781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524356781?lang=zh_tw&edition=fundamental","pubTime":"2025-04-04 22:51","pubTimestamp":1743778285,"startTime":"0","endTime":"0","summary":"北京时间2025年04月04日22时51分，Igc Pharma, Inc.股票出现波动，股价快速跳水5.23%。Igc Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.71%。Igc Pharma, Inc.公司简介：IGC Pharma Inc 开发先进的基于大麻素的配方，用于治疗疾病和病症，包括但不限于阿尔茨海默病、痛经、经前综合症和慢性疼痛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404225125972e85a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404225125972e85a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IGC","IBO","BK4104"],"gpt_icon":0},{"id":"2524781983","title":"Tnf Pharmaceuticals, Inc.盤中異動跌3.41% 換手率達43.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524781983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524781983?lang=zh_tw&edition=fundamental","pubTime":"2025-04-04 22:51","pubTimestamp":1743778282,"startTime":"0","endTime":"0","summary":"北京时间2025年04月04日22时51分，Tnf Pharmaceuticals, Inc.股票出现波动，股价大幅下挫3.41%。截至发稿，该股报0.390美元/股，成交量120.618万股，换手率43.78%，振幅8.66%。Tnf Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.71%。Tnf Pharmaceuticals, Inc.公司简介：TNF Pharmaceuticals Inc是一家临床阶段的制药公司，致力于延长健康的寿命。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404225122aa2c5c07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404225122aa2c5c07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4113","IBO","TNFA","CBD","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":80,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBO\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IBO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IBO","date":"2025-04-17","current":-0.21375,"percent":0.372414,"low":-7.852882,"twenty":-4.19723,"median":14.416973,"eighty":21.230475,"high":48.978211,"avg":10.218026,"sd":12.543727,"marketCap":5281325},"quantilePoints":[{"date":"2024-09-20","current":-6.823884,"twenty":-6.997189,"median":-6.647871,"eighty":-6.406869,"marketCap":28974211},{"date":"2024-09-27","current":-6.471858,"twenty":-6.910536,"median":-6.471858,"eighty":-6.309385,"marketCap":27479510},{"date":"2024-10-04","current":-4.468019,"twenty":-6.775142,"median":-6.309385,"eighty":-5.239768,"marketCap":18971209},{"date":"2024-10-11","current":-4.260324,"twenty":-6.580174,"median":-5.415781,"eighty":-4.180929,"marketCap":18089336},{"date":"2024-10-18","current":-3.864701,"twenty":-6.471858,"median":-5.077294,"eighty":-4.002262,"marketCap":16409521},{"date":"2024-10-25","current":-4.738808,"twenty":-6.374374,"median":-4.468019,"eighty":-3.910194,"marketCap":20120980},{"date":"2024-10-31","current":-5.984438,"twenty":-6.309385,"median":-5.036676,"eighty":-3.937273,"marketCap":25409923},{"date":"2024-11-08","current":-7.552848,"twenty":-6.791389,"median":-5.368393,"eighty":-3.986015,"marketCap":32069393},{"date":"2024-11-15","current":24.785345,"twenty":-7.039432,"median":-5.415781,"eighty":-3.937273,"marketCap":28874927},{"date":"2024-11-22","current":25.871555,"twenty":-6.952238,"median":-5.077294,"eighty":-3.531089,"marketCap":30140362},{"date":"2024-11-29","current":28.833947,"twenty":-6.807637,"median":-4.603414,"eighty":19.151303,"marketCap":33591548},{"date":"2024-12-06","current":22.514178,"twenty":-6.688489,"median":-4.260324,"eighty":24.785345,"marketCap":26229017},{"date":"2024-12-13","current":21.230475,"twenty":-6.471858,"median":-4.053712,"eighty":24.548354,"marketCap":24733503},{"date":"2024-12-20","current":16.490647,"twenty":-6.439363,"median":-3.95352,"eighty":23.560889,"marketCap":19211604},{"date":"2024-12-27","current":15.799423,"twenty":-6.309385,"median":-3.885823,"eighty":23.402895,"marketCap":18406328},{"date":"2025-01-03","current":15.206944,"twenty":-6.309385,"median":-3.628573,"eighty":23.007909,"marketCap":17716090},{"date":"2025-01-10","current":17.774351,"twenty":-6.27689,"median":-3.439292,"eighty":22.790667,"marketCap":20707119},{"date":"2025-01-17","current":15.898169,"twenty":-6.092754,"median":12.787657,"eighty":22.593175,"marketCap":18521367},{"date":"2025-01-24","current":15.503184,"twenty":-5.93028,"median":14.167144,"eighty":22.435181,"marketCap":18061209},{"date":"2025-01-31","current":18.308568,"twenty":-5.773222,"median":14.515719,"eighty":22.000696,"marketCap":21329482},{"date":"2025-02-07","current":18.663068,"twenty":-5.562007,"median":14.960078,"eighty":21.408218,"marketCap":21742474},{"date":"2025-02-14","current":21.230475,"twenty":-5.415781,"median":15.40345,"eighty":21.8822,"marketCap":24733503},{"date":"2025-02-21","current":19.749279,"twenty":-5.396826,"median":15.503184,"eighty":21.526713,"marketCap":23007910},{"date":"2025-02-28","current":15.206944,"twenty":-5.280387,"median":15.799423,"eighty":21.467465,"marketCap":17716090},{"date":"2025-03-07","current":11.948313,"twenty":-5.101666,"median":15.503184,"eighty":21.230475,"marketCap":13919785},{"date":"2025-03-14","current":6.617983,"twenty":-4.977102,"median":15.305197,"eighty":21.210726,"marketCap":7709950},{"date":"2025-03-21","current":20.53925,"twenty":-4.68465,"median":15.206944,"eighty":21.092229,"marketCap":23928226},{"date":"2025-03-28","current":22.514178,"twenty":-4.44094,"median":15.403944,"eighty":21.526713,"marketCap":26229017},{"date":"2025-04-04","current":-0.226956,"twenty":-4.318165,"median":15.206944,"eighty":21.467465,"marketCap":5607631},{"date":"2025-04-11","current":-0.249456,"twenty":-4.247705,"median":14.713213,"eighty":21.230475,"marketCap":6163560},{"date":"2025-04-17","current":-0.21375,"twenty":-4.19723,"median":14.416973,"eighty":21.230475,"marketCap":5281325}],"updateTime":1745092658151}}}